Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 1
1984 1
1986 1
1988 1
1990 1
1992 1
1995 1
1996 7
1997 5
1998 1
2000 5
2001 7
2002 7
2003 11
2004 6
2005 8
2006 23
2007 9
2008 13
2009 17
2010 21
2011 20
2012 21
2013 25
2014 29
2015 18
2016 23
2017 28
2018 24
2019 21
2020 33
2021 28
2022 29
2023 22
2024 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

430 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Lixisenatide in Early Parkinson's Disease.
Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group. Meissner WG, et al. Among authors: devos d. N Engl J Med. 2024 Apr 4;390(13):1176-1185. doi: 10.1056/NEJMoa2312323. N Engl J Med. 2024. PMID: 38598572 Clinical Trial.
Therapeutic inhibition of ferroptosis in neurodegenerative disease.
Ryan SK, Ugalde CL, Rolland AS, Skidmore J, Devos D, Hammond TR. Ryan SK, et al. Among authors: devos d. Trends Pharmacol Sci. 2023 Oct;44(10):674-688. doi: 10.1016/j.tips.2023.07.007. Epub 2023 Aug 30. Trends Pharmacol Sci. 2023. PMID: 37657967 Review.
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
Trial of Botulinum Toxin for Isolated or Essential Head Tremor.
Marques A, Pereira B, Simonetta-Moreau M, Castelnovo G, De Verdal M, Fluchère F, Laurencin C, Degos B, Tir M, Kreisler A, Blanchet-Fourcade G, Guehl D, Colin O, Poujois A, Sangla S, Tatu L, Derost P, Gayraud D, Tranchant C, Amarantini D, Devos D, Rascol O, Corvol JC, Durif F, Rieu I; Btx-HT Study Group. Marques A, et al. Among authors: devos d. N Engl J Med. 2023 Nov 9;389(19):1753-1765. doi: 10.1056/NEJMoa2304192. N Engl J Med. 2023. PMID: 37937777 Clinical Trial.
David Devos.
Devos D. Devos D. Lancet Neurol. 2012 Jul;11(7):576. doi: 10.1016/S1474-4422(12)70149-7. Lancet Neurol. 2012. PMID: 22710753 No abstract available.
Evolution of the nucleus.
Devos DP, Gräf R, Field MC. Devos DP, et al. Curr Opin Cell Biol. 2014 Jun;28(100):8-15. doi: 10.1016/j.ceb.2014.01.004. Epub 2014 Feb 6. Curr Opin Cell Biol. 2014. PMID: 24508984 Free PMC article. Review.
Virtually reducing fall risk in Parkinson disease.
Moreau C, Barton BR, Devos D. Moreau C, et al. Among authors: devos d. Neurology. 2017 Oct 24;89(17):1762-1763. doi: 10.1212/WNL.0000000000004581. Epub 2017 Sep 27. Neurology. 2017. PMID: 28954881 No abstract available.
Gemmata obscuriglobus.
Devos DP. Devos DP. Curr Biol. 2013 Sep 9;23(17):R705-7. doi: 10.1016/j.cub.2013.07.013. Curr Biol. 2013. PMID: 24028944 Free article. No abstract available.
430 results